Reaction Details |
| Report a problem with these data |
Target | HIV-1 protease |
---|
Ligand | BDBM468563 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Enzyme Inhibition of Purified HIV-1 Protease |
---|
IC50 | 0.210±n/a nM |
---|
Citation | Jude-Fishburn, CS; VanderVeen, LA; Riley, TA Protease inhibitors having enhanced features US Patent US10806794 Publication Date 10/20/2020 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
HIV-1 protease |
---|
Name: | HIV-1 protease |
Synonyms: | HIV-1 protease wild type |
Type: | Protein |
Mol. Mass.: | 10757.68 |
Organism: | Human immunodeficiency virus |
Description: | O90785 |
Residue: | 99 |
Sequence: | PQITLWQRPLVTVKIGGQLREALLDTGADDTVLEDINLPGKWKPKMIGGIGGFIKVKQYE
QVLIEICGKKAIGTVLVGPTPVNIIGRNMLTQIGCTLNF
|
|
|
BDBM468563 |
---|
n/a |
---|
Name | BDBM468563 |
Synonyms: | US10806794, Compound mPEG5-O-Darunavir |
Type | Small organic molecule |
Emp. Form. | C38H59N3O13S |
Mol. Mass. | 797.952 |
SMILES | COCCOCCOCCOCCOCCOc1ccc(C[C@H](NC(=O)O[C@H]2CO[C@H]3OCC[C@@H]23)C(O)CN(CC(C)C)S(=O)(=O)c2ccc(N)cc2)cc1 |r| |
Structure |
|